Table 1.
Sample * | Clean Reads | Clean Bases | ≥Q30 (%) | GC Content (%) | Total Mapped (%) | Uniquely Mapped (%) |
---|---|---|---|---|---|---|
NPR1_1 | 62,607,264 | 7.91G | 92.89 | 44.84 | 47,656,347 (76.12%) | 46,101,606 (73.64%) |
NPR1_2 | 59,175,150 | 7.40G | 92.79 | 45.23 | 45,972,884 (77.69%) | 44,572,333 (75.32%) |
NPR1_3 | 59,225,298 | 7.41G | 92.58 | 44.92 | 47,206,105 (79.71%) | 45,624,108 (77.03%) |
Val_1 | 65,551,728 | 8.20G | 92.44 | 44.4 | 54,260,656 (82.78%) | 52,711,952 (80.41%) |
Val_2 | 65,372,880 | 8.18G | 92.84 | 44.19 | 54,287,742 (83.04%) | 52,522,887 (80.34%) |
Val_3 | 61,717,406 | 7.72G | 92.7 | 44.59 | 51,647,046 (83.68%) | 50,005,354 (81.02%) |
Total/Average | 373,649,726 | 47.00G | 92.71 | 44.69 | 50,171,797 (80.50%) | 48,589,707 (77.96%) |
* NPR1_1/2/3 represent three replicates of NPR1-2 line while Val_1/2/3 represent three replicates of the control non-transgenic ‘Valencia’ line.